🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Medium Vessel Occlusion

Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion NCT07668323Phase 31 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Recombinant Tissue Plasminogen Activator (rt-PA), Intra-arterial Thrombolysis, Best Medical Management, Rescue therapy OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion NCT07137832Phase 31 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Primary intra-arterial thrombolysis, Standard medical treatment Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke NCT07776873Phase 31 site📍 Hefei The First Affiliated Hospital of Anhui Medical University · Tests: Recombinant Human Prourokinase for Injection (rhPro-UK), Standard medical treatment (SMT) Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke NCT07357987Phase 31 site📍 Beijing Beijing Tiantan Hospital · Tests: Intra-arterial Tenecteplase, standard medical management Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke NCT06559436NA1 site📍 Hefei The First Affiliated Hospital of University of Science and … · Tests: Intravenous thrombolysis, Standard medical management Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe NCT05983757NA4 sites📍 Atlanta📍 Iowa City📍 Toledo Raul Nogueira · Tests: Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion, Standard medical manag… Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS) NCT06125236n/a1 site📍 Luzhou Zhengzhou Yuan · Tests: Visit at D90 Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO) NCT07357285NA11 sites📍 Bonn📍 Kiel📍 Marburg iVascular S.L.U. · Tests: Thromboaspiration catheter Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes NCT07837934Phase 21 site📍 Singapore Tan Tock Seng Hospital · Tests: Colchicine 0.5 MG Oral Tablet Once Daily, Placebo Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2) NCT07375966Phase 21 site📍 Shenyang General Hospital of Shenyang Military Region · Tests: Tenecteplase Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion NCT07302854Phase 2, Phase 31 site📍 Wuhan Xiang Luo · Tests: Intra-arterial Thrombolysis, Standard medical treatment A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke NCT06712004Phase 21 site📍 Guangzhou Zhujiang Hospital · Tests: Bevifibatide citrate injection Improving Stroke Care in North-Norway Through Artificial Intelligence NCT05903898NA1 site📍 Tromsø University Hospital of North Norway · Tests: AI software StrokeSens (Circle NVI) Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion NCT05779215n/a1 site📍 Beijing Xuanwu Hospital, Beijing · Tests: Visit at D90 PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Registry NCT07746947n/a1 site📍 Indianapolis Indiana University Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy NCT07323368NA6 sites📍 Beijing📍 Beijing📍 Longzhou Beijing Tiantan Hospital · Tests: Endovascular treatment, Best medical treatment (BMT) SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective NCT06373601NA10 sites📍 Mercogliano📍 Bergamo📍 Brescia Fondazione Evidence per Attività e Ricerche Cardiovascolari… · Tests: sirolimus-eluting balloon (Selution), paclitaxel-eluting balloon (SeQuent Please Neo) GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry NCT06325800n/a1 site📍 Santiago de Compostela Complejo Hospitalario Universitario de Santiago · Tests: Multimodal Cardiovascular Phenotyping Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke NCT07047014Phase 37 sites📍 Beijing📍 Jiuquan📍 Shijiazhuang Beijing Tiantan Hospital · Tests: Tenecteplase (0.25mg/kg), Standard medical treatment Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase NCT07550296Phase 21 site📍 Shenyang General Hospital of Shenyang Military Region · Tests: prourokinase Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion NCT07185022NA6 sites📍 Fuyang📍 Fuyang📍 Hefei The Second Hospital of Anhui Medical University · Tests: Intra-arterial Thrombolysis, Best Medical Treatment Study on the Accuracy of Determining the Responsible Vessel in Medium Vessel Occlusive Stroke Based on Multi-type CT Evaluation NCT07347587n/a1 site📍 Beijing Xuanwu Hospital, Beijing
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy